Yuhua Liu

Key Laboratory Of Growth Regulation And Translational Research Of Zhejiang Province
Hangzhou, 310030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy.

In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy.

Journal: Science translational medicine

Published: March 25, 2026

Tumor-Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities.

Tumor-Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 14, 2026

Eosinophils: pathological mechanisms and novel targeted therapeutic strategies across multiple disease spectrums.

Eosinophils: pathological mechanisms and novel targeted therapeutic strategies across multiple disease spectrums.

Journal: Journal of leukocyte biology

Published: October 15, 2025

Recent advances in adoptive cell therapy for cancer immunotherapy.

Recent advances in adoptive cell therapy for cancer immunotherapy.

Journal: Frontiers in immunology

Published: July 17, 2025

Erythrocyte-anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial.

Erythrocyte-anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial.

Journal: Nature cancer

Published: December 11, 2024

Developing an erythrocyte‒MHC-I conjugate for cancer treatment.

Developing an erythrocyte‒MHC-I conjugate for cancer treatment.

Journal: Cell discovery

Published: December 24, 2023

Combined Detection of IFN-γ and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times.

Combined Detection of IFN-γ and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times.

Journal: Current microbiology

Published: August 25, 2022

Opposite effects of miR-155 in the initial and later stages of lipopolysaccharide (LPS)-induced inflammatory response.

Opposite effects of miR-155 in the initial and later stages of lipopolysaccharide (LPS)-induced inflammatory response.

Journal: Journal of Zhejiang University. Science. B

Published: July 16, 2021

Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.

Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.

Journal: Journal of medical virology

Published: May 19, 2017

miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.

miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.

Journal: OncoTargets and therapy

Published: May 27, 2016

Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.

Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.

Journal: Oncoimmunology

Published: May 01, 2015

Gr-1⁺CD11b⁺ immature myeloid cells (IMC) promote resistance of pro-inflammatory T cells to suppression by regulatory T cells in atherosclerotic Apo E- deficient mice.

Gr-1⁺CD11b⁺ immature myeloid cells (IMC) promote resistance of pro-inflammatory T cells to suppression by regulatory T cells in atherosclerotic Apo E- deficient mice.

Journal: PloS one

Published: May 15, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026